Ararat Capital Management LP boosted its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 13.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,281,912 shares of the company's stock after acquiring an additional 269,346 shares during the period. Integral Ad Science accounts for 9.5% of Ararat Capital Management LP's holdings, making the stock its 3rd biggest position. Ararat Capital Management LP owned about 1.40% of Integral Ad Science worth $23,823,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in the business. Jennison Associates LLC lifted its position in Integral Ad Science by 3.3% during the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock worth $663,000 after acquiring an additional 2,046 shares during the last quarter. Oppenheimer & Co. Inc. increased its stake in shares of Integral Ad Science by 8.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 28,040 shares of the company's stock valued at $293,000 after purchasing an additional 2,069 shares during the last quarter. Envestnet Asset Management Inc. grew its position in Integral Ad Science by 7.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock valued at $332,000 after acquiring an additional 2,188 shares during the last quarter. Arizona State Retirement System increased its position in Integral Ad Science by 12.5% during the 4th quarter. Arizona State Retirement System now owns 23,404 shares of the company's stock worth $244,000 after purchasing an additional 2,601 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its stake in shares of Integral Ad Science by 8.9% in the 4th quarter. Victory Capital Management Inc. now owns 32,880 shares of the company's stock valued at $343,000 after acquiring an additional 2,695 shares during the last quarter. Institutional investors and hedge funds own 95.78% of the company's stock.
Insiders Place Their Bets
In related news, CEO Lisa Utzschneider sold 8,547 shares of the business's stock in a transaction dated Monday, April 7th. The stock was sold at an average price of $6.85, for a total transaction of $58,546.95. Following the completion of the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at $2,337,706.35. The trade was a 2.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 77,855 shares of company stock worth $574,587 in the last quarter. 2.00% of the stock is owned by company insiders.
Integral Ad Science Stock Up 5.1 %
IAS stock traded up $0.38 during trading on Thursday, reaching $7.76. The stock had a trading volume of 319,908 shares, compared to its average volume of 999,786. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 38.80, a P/E/G ratio of 1.06 and a beta of 1.55. Integral Ad Science Holding Corp. has a one year low of $6.26 and a one year high of $13.62. The company's 50 day moving average is $7.97 and its two-hundred day moving average is $9.78.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million for the quarter, compared to analysts' expectations of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business's quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter last year, the business posted $0.06 EPS. Equities research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.
Analyst Ratings Changes
IAS has been the topic of several recent research reports. Morgan Stanley cut their target price on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a research report on Thursday, April 17th. Barclays cut their price objective on Integral Ad Science from $14.00 to $7.00 and set an "equal weight" rating on the stock in a research note on Monday, April 21st. Robert W. Baird restated a "neutral" rating and set a $9.00 price target (down previously from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Scotiabank initiated coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They set a "sector perform" rating and a $12.00 target price for the company. Finally, Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $13.15.
View Our Latest Stock Report on Integral Ad Science
Integral Ad Science Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
See Also

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.